去氨加压素对单症状遗尿症患儿症状及睡眠质量影响

doi:10.12372/jcp.2022.21e1237

Abstract

Abstract: Objectives To investigate the improvement of symptoms and sleep in children with monosymptomatic nocturnal enuresis (MNE) treated with desmopressin (DDAVP). Methods A total of 69 children with MNE who were treated in our clinic from 2018 to 2020 were selected for a 12-week follow-up study of DDAVP treatment. After 12 weeks, the children were divided into improvement group and non-improvement group according to the remission of enuresis, and the effect of DDAVP treatment on enuresis symptoms and sleep quality was analyzed. Results Among the 69 children with MNE enrolled at baseline, 7 dropped out of the follow-up, and 62 were eventually included, including 34 boys and 28 girls, with an average age of (8.77±1.94) years. In all MNE children treated with DDAVP, there were statistically significant differences in the number of enuresis nights, total score of the children's sleep habits questionnaire (CSHQ), occurrence time of enuresis, and sleep time on weekdays and weekends between baseline, weeks 4, 8 and 12 (P<0.05). Compared with baseline, the number of enuresis nights and the total score of CSHQ at week 12 were significantly decreased, and the occurrence time of enuresis and sleep time on weekdays and weekends were significantly prolonged, and the differences were statistically significant (P<0.05). Compared with the non-improvement group (n=22), the improvement group (n=40) at week 8 and 12 had lower CSHQ scores, significantly longer enuresis occurrence time, sleep time on weekdays and weekends, and fewer enuresis nights per week, and the differences were statistically significant (P<0.05). In terms of CSHQ scores at 8 levels, there were statistically significant differences in the scores of sleeping habits, sleep latency, bedtime duration, sleep anxiety, night waking, parasomnias and daytime sleepiness in the improvement group (P<0.05), while there was statistically significant difference only in bedtime duration in the non-improvement group (P<0.05).Conclusion DDAVP treatment for 12 weeks can significantly improve the symptoms and sleep quality of children with MNE.

Key words: desmopressin, monosymptomatic nocturnal enuresis, sleep, child

LYU Lei, WANG Yihe, HU Huijie, ZHAO Ying, LIU Erpeng, ZHANG Yanping, PU Qingsong, YANG Xinghuan, JI Fengping, WEN Jianguo. Effects of desmopressin on symptoms and sleep quality in children with monosymptomatic nocturnal enuresis[J].Journal of Clinical Pediatrics, 2022, 40(4): 294-299.

Figures/Tables 3

References 22

[1]	中华医学会小儿外科学分会小儿尿动力和盆底学组和泌尿外科学组. 儿童遗尿症诊断和治疗中国专家共识[J]. 中华医学杂志, 2019, 99(21):1615-1620.
[2]	韩中将, 文一博, 汪玺正, 等. 儿童原发性遗尿症不同亚型患病率调查[J]. 中华小儿外科杂志, 2019, 40(12):1118-1122.
[3]	沈茜, 刘小梅, 姚勇, 等. 中国儿童单症状性夜遗尿疾病管理专家共识[J]. 临床儿科杂志, 2014, 32(10):970-975.
[4]	Austin PF, Bauer SB, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children's Continence Society[J]. Neurourol Urodyn, 2016, 35(4):471-481. doi: 10.1002/nau.22751
[5]	Neveus T, Eggert P, Evans J, et al. Evaluation of and treatment for monosymptomatic enuresis: a standardization document from the International Children's Continence Society[J]. J Urol, 2010, 183(2):441-447. doi: 10.1016/j.juro.2009.10.043
[6]	Jain S, Bhatt GC. Advances in the management of primary monosymptomatic nocturnal enuresis in children[J]. Paediatr Int Child Health, 2016, 36(1):7-14. doi: 10.1179/2046905515Y.0000000023
[7]	Tan TX, Wang Y, Cheah CSL, et al. Reliability and construct validity of the Children's Sleep Habits Questionnaire in Chinese kindergartners[J]. Sleep Health, 2018, 4(1):104-109. doi: 10.1016/j.sleh.2017.10.008
[8]	Radmayr C, Bogaert G, Dogan H, et al. EAU guidelines on paediatric urology[M]. EAU Guidelines, edition presented at the annual EAU Congress Barcelona. EAU. 2019.
[9]	Tsuji S, Takewa R, Ohnuma C, et al. Nocturnal enuresis and poor sleep quality[J]. Pediatr Int, 2018, 60(11):1020-1023. doi: 10.1111/ped.2018.60.issue-11
[10]	Ma J, Li S, Jiang F, et al. Relationship between sleep patterns, sleep problems, and childhood enuresis[J]. Sleep Med, 2018, 50:14-20. doi: 10.1016/j.sleep.2018.05.022
[11]	Dossche L, Raes A, Hoebeke P, et al. Circadian Rhythm of Glomerular Filtration and Solute Handling Related to Nocturnal Enuresis[J]. J Urol, 2016, 195(1):162-167. doi: 10.1016/j.juro.2015.07.079 pmid: 26192252
[12]	Borg B, Kamperis K, Olsen LH, et al. Evidence of reduced bladder capacity during nighttime in children with monosymptomatic nocturnal enuresis[J]. J Pediatr Urol, 2018, 14(2): 160.e1-160.e6. doi: 10.1016/j.jpurol.2017.09.021
[13]	Kamperis K, Van Herzeele C, Rittig S, et al. Optimizing response to desmopressin in patients with monosymp-tomatic nocturnal enuresis[J]. Pediatr Nephrol, 2017, 32(2):217-226. doi: 10.1007/s00467-016-3376-7
[14]	Bogaert G, Stein R, Undre S, et al. Practical recom-mendations of the EAU-ESPU guidelines committee for monosymptomatic enuresis-Bedwetting[J]. Neurourol Urodyn, 2020, 39(2):489-497. doi: 10.1002/nau.v39.2
[15]	Chung E. Desmopressin and nocturnal voiding dysfunction: clinical evidence and safety profile in the treatment of nocturia[J]. Expert Opin Pharmacother, 2018, 19(3):291-298. doi: 10.1080/14656566.2018.1429406 pmid: 29376448
[16]	Pedersen MJ, Rittig S, Jennum PJ, et al. The role of sleep in the pathophysiology of nocturnal enuresis[J]. Sleep Med Rev, 2020, 49:101228. doi: 10.1016/j.smrv.2019.101228
[17]	Soster LA, Alves RC, Fagundes SN, et al. Non-REM sleep instability in children with primary monosymptomatic sleep enuresis[J]. J Clin Sleep Med, 2017, 13(10):1163-1170. doi: 10.5664/jcsm.6762
[18]	Dhondt K, Baert E, Van Herzeele C, et al. Sleep frag-mentation and increased periodic limb movements are more common in children with nocturnal enuresis[J]. Acta Paediatr, 2014, 103(6):e268-e272. doi: 10.1111/apa.12610
[19]	Van Herzeele C, Dhondt K, Roels SP, et al. Desmopressin (melt) therapy in children with monosymptomatic nocturnal enuresis and nocturnal polyuria results in improved neuropsychological functioning and sleep[J]. Pediatr Nephrol, 2016, 31(9):1477-1484. doi: 10.1007/s00467-016-3351-3
[20]	Rahm C, Schulz-Juergensen S, Eggert P. Effects of desmopressin on the sleep of children suffering from enuresis[J]. Acta Paediatr, 2010, 99(7):1037-1041. doi: 10.1111/apa.2010.99.issue-7
[21]	Bliwise DL, Holm-Larsen T, Goble S, et al. Delay of first voiding episode is associated with longer reported sleep duration[J]. Sleep health, 2015, 1(3):211-213. doi: S2352-7218(15)00105-9 pmid: 29073442
[22]	Gozmen S, Keskin S, Akil I. Enuresis nocturna and sleep quality[J]. Pediatr Nephrol, 2008, 23(8):1293-1296. doi: 10.1007/s00467-008-0817-y pmid: 18506489

项目	基线	第4周	第8周	第12周	统计量	P
每周遗尿夜晚数[M(P₂₅~P₇₅)]	4.0(3.0~4.3)	3.0(3.0~4.0)	3.0(2.0~3.0)	2.0(1.0~3.3)¹⁾	H=46.92	<0.001
CSHQ总分(x±s)	61.1±4.5	59.3±4.7	55.8±4.2	53.7±4.8¹⁾	F=33.84	<0.001
遗尿发生时间(x±s)/min	109.8±24.8	126.3±21.1	146.0±24.8	170.9±28.5¹⁾	F=69.01	<0.001
每日睡眠时间(x±s)/min
平时	562.2±33.1	577.7±32.2	587.4±28.55	593.4±31.8¹⁾	F=11.66	<0.001
周末	582.9±38.6	597.1±45.6	607.6±37.6	621.8±39.3¹⁾	F=10.27	<0.001

项目	改善组(n=40)	无改善组(n=22)	统计量	P
年龄(x±s)/岁	8.8±2.1	8.7±1.6	t=0.28	0.783
男性[n(%)]	23(57.5)	11(50.0)	χ²=0.32	0.570
每周遗尿夜晚数[M(P₂₅~P₇₅)]
基线	4.0(3.0~5.0)	4.0(3.0~4.0)	Z=1.06	0.287
第4周	3.0(3.0~4.0)	3.0(2.8~4.0)	Z=1.47	0.142
第8周	2.0(2.0~3.0)	3.0(3.0~3.0)	Z=2.84	0.005
第12周	1.5(1.0~2.0)	3.0(3.0~4.0)	Z=4.39	<0.001
遗尿发生时间(x±s)/min
基线	105.3±25.9	118.1±20.7	t=2.00	0.051
第4周	125.9±24.2	127.0±14.2	t=0.20	0.839
第8周	151.6±25.7	135.8±19.7	t=2.51	0.015
第12周	176.5±31.6	160.7±18.4	t=2.15	0.036
平时睡眠时间(x±s)/min
基线	561.5±32.8	563.5±34.5	t=0.23	0.821
第4周	584.0±33.2	566.1±27.2	t=2.17	0.034
第8周	595.8±28.2	572.2±22.6	t=3.37	0.001
第12周	601.0±30.8	579.7±29.5	t=2.64	0.011
周末睡眠时间(x±s)/min
基线	583.6±40.4	581.5±36.1	t=0.21	0.838
第4周	605.2±42.8	582.4±47.9	t=1.92	0.060
第8周	616.7±35.7	590.9±35.8	t=2.73	0.008
第12周	634.7±35.5	598.2±35.3	t=3.89	<0.001
CSHQ总分(x±s)
基线	61.8±4.6	60.0±4.2	t=1.48	0.144
第4周	59.3±5.1	59.3±4.1	t=0.03	0.973
第8周	54.8±4.4	57.7±3.1	t=2.78	0.007
第12周	52.0±4.6	56.7±3.3	t=4.25	<0.001

项目	组别	CSHQ评分				F值	P
项目	组别	基线	第4周	第8周	第12周	F值	P
就寝习惯	改善	12.1±1.1	11.4±1.3	10.3±1.4	9.2±1.3	39.11	<0.001
就寝习惯	无改善	11.7±1.0	11.6±1.2	11.1±0.9	11.1±0.9	2.43	0.071
入睡潜伏期	改善	2.6±0.6	2.4±0.6	1.9±0.5	1.5±0.5	31.52	<0.001
入睡潜伏期	无改善	2.3±0.7	2.2±0.5	2.1±0.5	2.1±0.7	0.68	0.569
睡眠持续时间	改善	6.0±0.8	5.7±0.9	4.9±0.8	4.4±1.0	29.19	<0.001
睡眠持续时间	无改善	5.9±0.8	5.8±0.8	5.5±0.7	5.2±0.7	3.27	0.025
睡眠焦虑	改善	9.9±1.2	9.2±1.4	8.4±1.2	7.8±1.3	21.73	<0.001
睡眠焦虑	无改善	9.3±1.0	9.3±0.9	9.1±1.1	8.6±0.9	2.24	0.089
夜醒	改善	3.8±0.8	4.1±0.8	4.3±0.7	4.6±1.0	7.56	<0.001
夜醒	无改善	4.2±0.7	4.2±0.8	4.2±0.6	4.3±0.8	0.17	0.916
异态睡眠	改善	11.7±1.0	11.4±1.1	10.9±0.9	10.6±1.0	10.20	<0.001
异态睡眠	无改善	11.6±1.1	11.5±1.2	11.1±1.0	10.8±1.0	2.38	0.075
睡眠呼吸暂停	改善	3.5±0.5	3.4±0.5	3.3±0.5	3.5±0.6	2.29	0.080
睡眠呼吸暂停	无改善	3.3±0.5	3.1±0.4	3.2±0.4	3.4±0.5	1.09	0.357
白天嗜睡	改善	12.3±1.3	11.9±1.3	10.9±1.1	10.3±1.3	19.56	<0.001
白天嗜睡	无改善	11.8±1.4	11.6±1.1	11.5±1.1	11.2±1.1	0.93	0.431

Effects of desmopressin on symptoms and sleep quality in children with monosymptomatic nocturnal enuresis

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 22

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LIN Jinfeng, CHEN Yi, DENG Yan, FENG Ai, HUANG Juan, CHEN Lizhu, XIE Jingqi, NIE Xiaojing. A comparative study on the detection of anti-Nephrin antibodies in children's nephrotic syndrome by chemiluminescence method and cell-based assay [J]. Journal of Clinical Pediatrics, 2026, 44(8): 682-689.
[2]	ZHENG Fangyuan, WANG Miao, DING Mingming, LU Aidong, JIA Yueping, ZENG Huimin, ZHANG Leping. Next-generation sequencing identified gene variants and their prognostic impact in pediatric Philadelphia chromosome positive acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2026, 44(8): 690-697.
[3]	ZHANG Xiao, FANG Hongjun, KUANG Xiaojun, WANG Lijuan, WU Zhao, JIANG Sha, LI Pei, WU Liwen. Analysis of the clinical and electrophysiological characteristics of atonic seizures in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 698-704.
[4]	WANG Mengqian, YANG Hui. Case series analysis of 13 intestinal Behcet’s syndrome in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 705-711.
[5]	WU Xirong, GAO Qi, GUO Siyuan, YIN Qingqin, QIN Qiang, YIN Ju, JIAO Anxia, CHEN Chenghao, WU Di, WANG Bei, DUAN Xiaomin, PENG Yun, XU Baoping, GAO Liwei. Clinical characteristics and prognosis of pulmonary mucormycosis in children with diabetes mellitus [J]. Journal of Clinical Pediatrics, 2026, 44(8): 712-720.
[6]	HAN Yanan, GE Lanlan, CUI Jieyuan. A case report of branchio-oto-renal syndrome caused by EYA1 gene variant with a 6-year follow-up [J]. Journal of Clinical Pediatrics, 2026, 44(8): 721-726.
[7]	SHI Jiayi, GAO Chunlin, JIA Lili, LU Yunyun, SUN Tao, ZHU Xiaodong, XIA Zhengkun, ZHANG Pei. Phenotypic characteristics and prognostic analysis of a pedigree with childhood isolated nephrotic syndrome caused by compound heterozygous mutations in the COQ2 gene [J]. Journal of Clinical Pediatrics, 2026, 44(8): 727-732.
[8]	Rachel Rosen, Osvaldo Borrelli, Christophe Faure, Katja Karrento, Usha Krishnan, Samuel Nurko, Nathalie Rommel, Alan Silverman, Michiel van Wijk, Marc Benninga (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: upper gastrointestinal disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 595-608.
[9]	Carlo Di Lorenzo, Miguel Saps, Bruno P. Chumpitazi, Shaman Rajindrajith, Annamaria Staiano, Nikhil Thapar, Miranda van Tilburg, Carlos Velasco-Benítez, Arine Vlieger (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: lower and biliary disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 609-621.
[10]	LI Xufeng, TANG Haoxun, LI Xingjun, ZHANG Lize, GAO Chenqing, ZHAO Shunying, LIU Jianhua. Clinical characteristics, chest CT imaging phenotypes, and their correlation with prognosis in 76 children with Chlamydia pneumoniae pneumonia [J]. Journal of Clinical Pediatrics, 2026, 44(7): 622-627.
[11]	WANG Zhen, SHAO Jingbo, ZHANG Na, XIA Min, ZHU Jiashi, DU Chengkan, LI Hong. Factors influencing long-term recurrence in pediatric acute lymphoblastic leukemia patients with low-risk disease at initial diagnosis: a five-year follow-up analysis of 254 cases from a single center [J]. Journal of Clinical Pediatrics, 2026, 44(7): 628-635.
[12]	GUO Xuemei, XUE Yao, WANG Yongren, RONG Liucheng, FANG Yongjun, LIN Rufeng. Clinical features and prognosis of childhood acute myeloid leukemia with CBFA2T3::GLIS2 fusion [J]. Journal of Clinical Pediatrics, 2026, 44(7): 636-643.
[13]	YANG Lijun, FU Dongxia, CUI Yan, YANG Junmei, ZHANG Liming. Clinical manifestation and genetic analysis of CHARGE syndrome caused by CHD7 gene variation [J]. Journal of Clinical Pediatrics, 2026, 44(7): 644-650.
[14]	HU Yan, YANG Fan, LIANG Aimin, MAO Meng. Identification and management of faltering growth in children: insights from the 13th International Conference on Nutrition and Growth [J]. Journal of Clinical Pediatrics, 2026, 44(6): 485-488.
[15]	LIU Ziyao, WANG Congying, WANG Hongmao, ZHANG Mingming, XU Yingjie, LAI Jianming, NIU Wenquan, LI Xiaohui. Early differentiation of Kawasaki disease with joint symptoms and systemic juvenile idiopathic arthritis with Kawasaki disease-like symptoms: a single-center retrospective study [J]. Journal of Clinical Pediatrics, 2026, 44(6): 489-498.